The 2023-2024 Cohort of AlphaLab Health is in full swing!
Innovation Works is a nationally prominent seed stage investor and has developed industry-leading accelerator programs, AlphaLab and AlphaLab Gear. Highmark Health and Allegheny Health Network make up one of the largest integrated healthcare delivery and finance systems in the country. By combining IW’s proven acceleration model with unparalleled clinical access and support, AlphaLab Health will surround you with the resources to accelerate your time to impact.
.png)
.png)
CytoAgents is a clinical-stage biotechnology company focused on the development of innovative pharmaceutical products for the treatment of life-threatening symptoms associated with Cytokine Release Syndrome (CRS), an overreaction of the immune system causing systemic inflammation. There are many causes of CRS and their mission is to develop a broadly accessible treatment for multiple indications of high unmet need. Using a novel approach by calming the natural immune response to a multi-organ disease, GP1681 is positioned to become a new best practice in medicine.
Telling.ai answers the question “how are your lungs doing” by giving users a detailed lung performance report by simply speaking into a smartphone. The company’s vision is to turn every smartphone in the world into a powerful remote respiratory monitoring device through a simple app and that will improve wellness and prevent unneeded hospitalizations and ED visits.
Handl Health is a healthcare price transparency platform. Handl offers health plans a simple way to comply with the CMS healthcare price transparency legislation while digitizing how patients shop, book, and pay for healthcare, creating an unparalleled user experience and realizing an average cost saving of 28%.
Maria is the Program Manager for Life Sciences where she focuses on the AlphaLab Health accelerator and the associated recruiting and operations. In this role, Maria is actively involved in the accelerator lifecycle from beginning to end and works closely with the companies, partners, and mentors participating in the program. She was a Graduate Research Assistant in the uBiointerface Lab at the University of Pittsburgh where she specialized in developing electrochemical methods for eradicating antibiotic-resistant bacteria. Previously, Maria served as a teaching assistant for the Hk Maker Lab, a summer engineering design program for NYC high school students, and selected projects to be incubated at the Harlem Biospace. Maria holds a BS degree in Biomedical Engineering from Columbia University and an MS degree in Bioengineering from the University of Pittsburgh.
Prior to joining Innovation Works, Cigdem worked at the innovation offices of the University of Pittsburgh and the University of Colorado Anschutz Medical Campus. In Colorado, she built and ran a biotechnology accelerator program called SPARK Colorado, in collaboration with Stanford University. Cigdem drafted and co-secured the NIH REACH grant, which enabled SPARK Colorado to receive $4M and become part of a national network of innovation hubs funded by the NIH. She was faculty at Boston College, a post-doctoral fellow at Harvard University, and a pre-doctoral fellow at Oxford University. She also worked at the Turkish Chambers of Commerce, running economic development and institutional capacity-building programs with international partners. Cigdem enjoys working with founders and thinking through challenges around the processes of innovation and venture formation, especially in life sciences, where the potential for direct impact is huge!
Dr. Cohen graduated in 1976 from Syracuse University with a BS in Biology. He earned his medical degree from SUNY – Upstate Medical Center in 1979, completed a Urology residency at Case Western Reserve in 1984 and finished a Fellowship in Urology Fellowship at The M.D. Anderson Cancer Center in 1985. He joined Allegheny General Hospital (AGH) in 1985. He was President of Triangle Urological Group, served as CMO of AGH 2013-2014 and was President of AGH from 2016-2020. Presently, he is the Chief Physician Executive, Community Health and Innovation. Dr. Cohen is President of Chemimage Corporation.
Stephen graduated in 2008 from Marietta College with a BA in Management Information Systems and an MBA from the University of Pittsburgh. He began his career with Deloitte working in the technology advisory practice and joined Highmark Health in 2012. His focus has been around developing and bringing Highmark Health’s long-term strategic vision to life. His concentration has been on the AHN’s $1B growth platform including Oncology, Wexford Hospital, north-west PA redevelopment, clinical mergers, and acquisitions. He was part of Highmark’s largest spin-up Home and Community Services (HMHCS).
You'll be able to meet virtually with a member of the AlphaLab Health team
)%20(1920%20%C3%97%201080%20px)%20(4).png)
